Deferiprone Not Beneficial for Newly Diagnosed Parkinson Disease
Greater decrease seen in nigrostriatal iron content with deferiprone, but more patients have symptom progression leading to initiation of dopaminergic therapy
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.